The Patent Finder
PR

Promega Corporation

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

183 patents currently held

17 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7 more records may belong here and await a decision; they are not counted.

The next term ends in Jan 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
49
Ending by 2030
Jan 2027
Next term end
93
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Oplophorus-Derived Luciferases, Novel Coelenterazine Substrates, and Methods of Use US 8,669,103
Cited by 91 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Ends Nov 2031 · High confidence
Also notable
Synthetic Oplophorus Luciferases with Enhanced Light Output US 8,557,970
The most cited patent in this portfolio, cited by 118 later US patents, top 5% of utility patents granted in 2013 in our data. Protection runs to 2030.
Ends Jul 2030 · High confidence
Also notable
Activation of Bioluminescence by Structural Complementation US 9,797,890
Cited by 28 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Ends Mar 2034 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Nov 23 to 30, 2026 · next Nov 23
  • 6 fees due Dec 2 to 16, 2026 · next Dec 2
  • 3 fees due Jan 4 to 30, 2027 · next Jan 4
  • 2 fees due Feb 4 to 28, 2027 · next Feb 4
  • 4 fees due Mar 3 to 26, 2027 · next Mar 3
  • 4 fees due Apr 1 to 30, 2027 · next Apr 1
  • 3 fees due Jun 8 to 24, 2027 · next Jun 8
  • 1 fee due Jul 2, 2027
    The maintenance fee for Quinone-Containing Conjugates (US 11,857,638) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 6 fees due Aug 2 to 27, 2027 · next Aug 2
  • 6 fees due Sep 1 to 26, 2027 · next Sep 1
  • 3 fees due Oct 14 to 28, 2027 · next Oct 14
  • 2 fees due Nov 12 to 17, 2027 · next Nov 12

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 22, 2026
  • 2 terms have ended since Aug 22, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,781,472Systems and Methods for Determining Cyclic Nucleotide Concentration and Related Pathway Activation
In force
 · High confidence
In forceHigh confidence
US 8,658,360Nucleic Acid Purification with a Binding Matrix
In force
 · High confidence
In forceHigh confidence
US 7,891,549Biological Sample Processing Apparatus That Selects the Personality Type of the Apparatus
In force
 · High confidence
In forceHigh confidence
US 7,951,550Luminogenic and Fluorogenic Compounds and Methods to Detect Molecules or Conditions
In force
 · High confidence
In forceHigh confidence
US 8,748,148Polynucleotides Encoding Mutant Hydrolase Proteins with Enhanced Kinetics and Functional Expression
In force
 · High confidence
In forceHigh confidence
US 9,593,316Polynucleotides Encoding Mutant Hydrolase Proteins with Enhanced Kinetics and Functional Expression
In force
 · High confidence
In forceHigh confidence
US 9,873,866Mutant Dehalogenase Proteins
In force
 · High confidence
In forceHigh confidence
US 10,246,690Mutant Hydrolase Proteins with Enhanced Kinetics and Functional Expression
In force
 · High confidence
In forceHigh confidence
US D695,295Adapter for Hand-Held Electronic Devices
In force
 · High confidence
In forceHigh confidence
US 9,012,164Bioluminescent Assays Utilising Secreted Luciferases
In force
 · High confidence
In forceHigh confidence
10 of 183 patents shown.
Pro members see all 183.
Pro members: see all 183 patents
Also on record, not counted in the 183: 17 patents in force now held by others · 114 patents ended · 42 applications pending · 66 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited